Epidarex

Epidarex Capital Portfolio Company SIRAKOSS Acquired by OSSDSIGN

Second significant value realisation this quarter highlights Epidarex’s successful approach to life science investing Bethesda, MD, USA, and Edinburgh, UK; November 3rd, 2020 – Epidarex Capital (“Epidarex”), a transatlantic life science venture firm, is pleased to announce its second value realisation this quarter with the…

Epidarex Continues Expansion of Its Team

Epidarex Capital, a leading transatlantic early stage life science venture capital firm, is delighted to announce that Russell Makepeace has joined its management team as Vice President of Finance and Administration. Russell is an international business executive with over 25 years of experience in finance, accounting…

Epidarex Capital Continues Expansion of its Team

Epidarex Capital, a leading early stage life science firm, is delighted to announce the addition of two veteran life science professionals to its transatlantic team.  Dr. Henning Steinhagen has joined as a Venture Partner and will support Epidarex in building exciting life science companies around…

Epidarex Expands Team

We are pleased to welcome Terri Burke to the Epidarex team.  Terri joins the Epidarex transatlantic team as a Venture Partner and will focus on developing and executing our upcoming funds’ MedTech strategy.  From her base in the U.S., Terri will be sourcing new investment…